TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Transdermal Patch Drug Delivery System Market Research Report 2022

Global Transdermal Patch Drug Delivery System Market Research Report 2022

  • Category:Life Sciences
  • Published on : 16 October 2022
  • Pages :104
  • Formats:
  • Report Code:SMR-7443403
OfferClick for best price

Best Price: $2320

Transdermal Patch Drug Delivery System Market Size, Share 2022


Market Analysis and Insights: Global Transdermal Patch Drug Delivery System Market

The global Transdermal Patch Drug Delivery System market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Transdermal Patch Drug Delivery System market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Transdermal Patch Drug Delivery System market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Transdermal Patch Drug Delivery System market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Transdermal Patch Drug Delivery System market.

Global Transdermal Patch Drug Delivery System Scope and Market Size

Transdermal Patch Drug Delivery System market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Transdermal Patch Drug Delivery System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Shunt Way

Intercellular Lipid Structure Pathway

Trans-cellular Pathway

Segment by Application

Hospital

Clinic

Home Care

Other

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

By Company

Hisamitsu Pharmaceutical

Novartis

ProSolus

Tapemark

Tesa Labtec

NITTO DENKO CORPORATION

Noven Pharmaceuticals

LTS Lohmann Therapie-Systeme

Medherant

Corium

Antares Pharma

Syntropharma

Teikoku Pharma

Mylan

Actavis

Mundipharma

Henan Lingrui Pharmaceutical

Changzhou Siyao

Rfl Pharmaceutical

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Transdermal Patch Drug Delivery System product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Transdermal Patch Drug Delivery System, with price, sales, revenue, and global market share of Transdermal Patch Drug Delivery System from 2019 to 2022.

Chapter 3, the Transdermal Patch Drug Delivery System competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Transdermal Patch Drug Delivery System breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Transdermal Patch Drug Delivery System market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Transdermal Patch Drug Delivery System.

Chapter 13, 14, and 15, to describe Transdermal Patch Drug Delivery System sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Transdermal Patch Drug Delivery System Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Transdermal Patch Drug Delivery System Market Research Report 2022
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 104 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transdermal Patch Drug Delivery System Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Shunt Way
1.2.3 Intercellular Lipid Structure Pathway
1.2.4 Trans-cellular Pathway
1.3 Market by Application
1.3.1 Global Transdermal Patch Drug Delivery System Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Care
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Transdermal Patch Drug Delivery System Market Perspective (2017-2028)
2.2 Transdermal Patch Drug Delivery System Growth Trends by Region
2.2.1 Transdermal Patch Drug Delivery System Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Transdermal Patch Drug Delivery System Historic Market Size by Region (2017-2022)
2.2.3 Transdermal Patch Drug Delivery System Forecasted Market Size by Region (2023-2028)
2.3 Transdermal Patch Drug Delivery System Market Dynamics
2.3.1 Transdermal Patch Drug Delivery System Industry Trends
2.3.2 Transdermal Patch Drug Delivery System Market Drivers
2.3.3 Transdermal Patch Drug Delivery System Market Challenges
2.3.4 Transdermal Patch Drug Delivery System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transdermal Patch Drug Delivery System Players by Revenue
3.1.1 Global Top Transdermal Patch Drug Delivery System Players by Revenue (2017-2022)
3.1.2 Global Transdermal Patch Drug Delivery System Revenue Market Share by Players (2017-2022)
3.2 Global Transdermal Patch Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Transdermal Patch Drug Delivery System Revenue
3.4 Global Transdermal Patch Drug Delivery System Market Concentration Ratio
3.4.1 Global Transdermal Patch Drug Delivery System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transdermal Patch Drug Delivery System Revenue in 2021
3.5 Transdermal Patch Drug Delivery System Key Players Head office and Area Served
3.6 Key Players Transdermal Patch Drug Delivery System Product Solution and Service
3.7 Date of Enter into Transdermal Patch Drug Delivery System Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Transdermal Patch Drug Delivery System Breakdown Data by Type
4.1 Global Transdermal Patch Drug Delivery System Historic Market Size by Type (2017-2022)
4.2 Global Transdermal Patch Drug Delivery System Forecasted Market Size by Type (2023-2028)
5 Transdermal Patch Drug Delivery System Breakdown Data by Application
5.1 Global Transdermal Patch Drug Delivery System Historic Market Size by Application (2017-2022)
5.2 Global Transdermal Patch Drug Delivery System Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Transdermal Patch Drug Delivery System Market Size (2017-2028)
6.2 North America Transdermal Patch Drug Delivery System Market Size by Country (2017-2022)
6.3 North America Transdermal Patch Drug Delivery System Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Transdermal Patch Drug Delivery System Market Size (2017-2028)
7.2 Europe Transdermal Patch Drug Delivery System Market Size by Country (2017-2022)
7.3 Europe Transdermal Patch Drug Delivery System Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transdermal Patch Drug Delivery System Market Size (2017-2028)
8.2 Asia-Pacific Transdermal Patch Drug Delivery System Market Size by Country (2017-2022)
8.3 Asia-Pacific Transdermal Patch Drug Delivery System Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Transdermal Patch Drug Delivery System Market Size (2017-2028)
9.2 Latin America Transdermal Patch Drug Delivery System Market Size by Country (2017-2022)
9.3 Latin America Transdermal Patch Drug Delivery System Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transdermal Patch Drug Delivery System Market Size (2017-2028)
10.2 Middle East & Africa Transdermal Patch Drug Delivery System Market Size by Country (2017-2022)
10.3 Middle East & Africa Transdermal Patch Drug Delivery System Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Hisamitsu Pharmaceutical
11.1.1 Hisamitsu Pharmaceutical Company Detail
11.1.2 Hisamitsu Pharmaceutical Business Overview
11.1.3 Hisamitsu Pharmaceutical Transdermal Patch Drug Delivery System Introduction
11.1.4 Hisamitsu Pharmaceutical Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.1.5 Hisamitsu Pharmaceutical Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Transdermal Patch Drug Delivery System Introduction
11.2.4 Novartis Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.2.5 Novartis Recent Development
11.3 ProSolus
11.3.1 ProSolus Company Detail
11.3.2 ProSolus Business Overview
11.3.3 ProSolus Transdermal Patch Drug Delivery System Introduction
11.3.4 ProSolus Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.3.5 ProSolus Recent Development
11.4 Tapemark
11.4.1 Tapemark Company Detail
11.4.2 Tapemark Business Overview
11.4.3 Tapemark Transdermal Patch Drug Delivery System Introduction
11.4.4 Tapemark Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.4.5 Tapemark Recent Development
11.5 Tesa Labtec
11.5.1 Tesa Labtec Company Detail
11.5.2 Tesa Labtec Business Overview
11.5.3 Tesa Labtec Transdermal Patch Drug Delivery System Introduction
11.5.4 Tesa Labtec Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.5.5 Tesa Labtec Recent Development
11.6 NITTO DENKO CORPORATION
11.6.1 NITTO DENKO CORPORATION Company Detail
11.6.2 NITTO DENKO CORPORATION Business Overview
11.6.3 NITTO DENKO CORPORATION Transdermal Patch Drug Delivery System Introduction
11.6.4 NITTO DENKO CORPORATION Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.6.5 NITTO DENKO CORPORATION Recent Development
11.7 Noven Pharmaceuticals
11.7.1 Noven Pharmaceuticals Company Detail
11.7.2 Noven Pharmaceuticals Business Overview
11.7.3 Noven Pharmaceuticals Transdermal Patch Drug Delivery System Introduction
11.7.4 Noven Pharmaceuticals Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.7.5 Noven Pharmaceuticals Recent Development
11.8 LTS Lohmann Therapie-Systeme
11.8.1 LTS Lohmann Therapie-Systeme Company Detail
11.8.2 LTS Lohmann Therapie-Systeme Business Overview
11.8.3 LTS Lohmann Therapie-Systeme Transdermal Patch Drug Delivery System Introduction
11.8.4 LTS Lohmann Therapie-Systeme Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.8.5 LTS Lohmann Therapie-Systeme Recent Development
11.9 Medherant
11.9.1 Medherant Company Detail
11.9.2 Medherant Business Overview
11.9.3 Medherant Transdermal Patch Drug Delivery System Introduction
11.9.4 Medherant Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.9.5 Medherant Recent Development
11.10 Corium
11.10.1 Corium Company Detail
11.10.2 Corium Business Overview
11.10.3 Corium Transdermal Patch Drug Delivery System Introduction
11.10.4 Corium Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.10.5 Corium Recent Development
11.11 Antares Pharma
11.11.1 Antares Pharma Company Detail
11.11.2 Antares Pharma Business Overview
11.11.3 Antares Pharma Transdermal Patch Drug Delivery System Introduction
11.11.4 Antares Pharma Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.11.5 Antares Pharma Recent Development
11.12 Syntropharma
11.12.1 Syntropharma Company Detail
11.12.2 Syntropharma Business Overview
11.12.3 Syntropharma Transdermal Patch Drug Delivery System Introduction
11.12.4 Syntropharma Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.12.5 Syntropharma Recent Development
11.13 Teikoku Pharma
11.13.1 Teikoku Pharma Company Detail
11.13.2 Teikoku Pharma Business Overview
11.13.3 Teikoku Pharma Transdermal Patch Drug Delivery System Introduction
11.13.4 Teikoku Pharma Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.13.5 Teikoku Pharma Recent Development
11.14 Mylan
11.14.1 Mylan Company Detail
11.14.2 Mylan Business Overview
11.14.3 Mylan Transdermal Patch Drug Delivery System Introduction
11.14.4 Mylan Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.14.5 Mylan Recent Development
11.15 Actavis
11.15.1 Actavis Company Detail
11.15.2 Actavis Business Overview
11.15.3 Actavis Transdermal Patch Drug Delivery System Introduction
11.15.4 Actavis Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.15.5 Actavis Recent Development
11.16 Mundipharma
11.16.1 Mundipharma Company Detail
11.16.2 Mundipharma Business Overview
11.16.3 Mundipharma Transdermal Patch Drug Delivery System Introduction
11.16.4 Mundipharma Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.16.5 Mundipharma Recent Development
11.17 Henan Lingrui Pharmaceutical
11.17.1 Henan Lingrui Pharmaceutical Company Detail
11.17.2 Henan Lingrui Pharmaceutical Business Overview
11.17.3 Henan Lingrui Pharmaceutical Transdermal Patch Drug Delivery System Introduction
11.17.4 Henan Lingrui Pharmaceutical Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.17.5 Henan Lingrui Pharmaceutical Recent Development
11.18 Changzhou Siyao
11.18.1 Changzhou Siyao Company Detail
11.18.2 Changzhou Siyao Business Overview
11.18.3 Changzhou Siyao Transdermal Patch Drug Delivery System Introduction
11.18.4 Changzhou Siyao Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.18.5 Changzhou Siyao Recent Development
11.19 Rfl Pharmaceutical
11.19.1 Rfl Pharmaceutical Company Detail
11.19.2 Rfl Pharmaceutical Business Overview
11.19.3 Rfl Pharmaceutical Transdermal Patch Drug Delivery System Introduction
11.19.4 Rfl Pharmaceutical Revenue in Transdermal Patch Drug Delivery System Business (2017-2022)
11.19.5 Rfl Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Transdermal Patch Drug Delivery System Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Shunt Way
Table 3. Key Players of Intercellular Lipid Structure Pathway
Table 4. Key Players of Trans-cellular Pathway
Table 5. Global Transdermal Patch Drug Delivery System Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Transdermal Patch Drug Delivery System Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Transdermal Patch Drug Delivery System Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Transdermal Patch Drug Delivery System Market Share by Region (2017-2022)
Table 9. Global Transdermal Patch Drug Delivery System Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Transdermal Patch Drug Delivery System Market Share by Region (2023-2028)
Table 11. Transdermal Patch Drug Delivery System Market Trends
Table 12. Transdermal Patch Drug Delivery System Market Drivers
Table 13. Transdermal Patch Drug Delivery System Market Challenges
Table 14. Transdermal Patch Drug Delivery System Market Restraints
Table 15. Global Transdermal Patch Drug Delivery System Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Transdermal Patch Drug Delivery System Market Share by Players (2017-2022)
Table 17. Global Top Transdermal Patch Drug Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Patch Drug Delivery System as of 2021)
Table 18. Ranking of Global Top Transdermal Patch Drug Delivery System Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Transdermal Patch Drug Delivery System Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Transdermal Patch Drug Delivery System Product Solution and Service
Table 22. Date of Enter into Transdermal Patch Drug Delivery System Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Transdermal Patch Drug Delivery System Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Transdermal Patch Drug Delivery System Revenue Market Share by Type (2017-2022)
Table 26. Global Transdermal Patch Drug Delivery System Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Transdermal Patch Drug Delivery System Revenue Market Share by Type (2023-2028)
Table 28. Global Transdermal Patch Drug Delivery System Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Transdermal Patch Drug Delivery System Revenue Market Share by Application (2017-2022)
Table 30. Global Transdermal Patch Drug Delivery System Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Transdermal Patch Drug Delivery System Revenue Market Share by Application (2023-2028)
Table 32. North America Transdermal Patch Drug Delivery System Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Transdermal Patch Drug Delivery System Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Transdermal Patch Drug Delivery System Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Transdermal Patch Drug Delivery System Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Transdermal Patch Drug Delivery System Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Transdermal Patch Drug Delivery System Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Transdermal Patch Drug Delivery System Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Transdermal Patch Drug Delivery System Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Transdermal Patch Drug Delivery System Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Transdermal Patch Drug Delivery System Market Size by Country (2023-2028) & (US$ Million)
Table 42. Hisamitsu Pharmaceutical Company Detail
Table 43. Hisamitsu Pharmaceutical Business Overview
Table 44. Hisamitsu Pharmaceutical Transdermal Patch Drug Delivery System Product
Table 45. Hisamitsu Pharmaceutical Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
Table 46. Hisamitsu Pharmaceutical Recent Development
Table 47. Novartis Company Detail
Table 48. Novartis Business Overview
Table 49. Novartis Transdermal Patch Drug Delivery System Product
Table 50. Novartis Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
Table 51. Novartis Recent Development
Table 52. ProSolus Company Detail
Table 53. ProSolus Business Overview
Table 54. ProSolus Transdermal Patch Drug Delivery System Product
Table 55. ProSolus Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
Table 56. ProSolus Recent Development
Table 57. Tapemark Company Detail
Table 58. Tapemark Business Overview
Table 59. Tapemark Transdermal Patch Drug Delivery System Product
Table 60. Tapemark Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
Table 61. Tapemark Recent Development
Table 62. Tesa Labtec Company Detail
Table 63. Tesa Labtec Business Overview
Table 64. Tesa Labtec Transdermal Patch Drug Delivery System Product
Table 65. Tesa Labtec Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
Table 66. Tesa Labtec Recent Development
Table 67. NITTO DENKO CORPORATION Company Detail
Table 68. NITTO DENKO CORPORATION Business Overview
Table 69. NITTO DENKO CORPORATION Transdermal Patch Drug Delivery System Product
Table 70. NITTO DENKO CORPORATION Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
Table 71. NITTO DENKO CORPORATION Recent Development
Table 72. Noven Pharmaceuticals Company Detail
Table 73. Noven Pharmaceuticals Business Overview
Table 74. Noven Pharmaceuticals Transdermal Patch Drug Delivery System Product
Table 75. Noven Pharmaceuticals Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
Table 76. Noven Pharmaceuticals Recent Development
Table 77. LTS Lohmann Therapie-Systeme Company Detail
Table 78. LTS Lohmann Therapie-Systeme Business Overview
Table 79. LTS Lohmann Therapie-Systeme Transdermal Patch Drug Delivery System Product
Table 80. LTS Lohmann Therapie-Systeme Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
Table 81. LTS Lohmann Therapie-Systeme Recent Development
Table 82. Medherant Company Detail
Table 83. Medherant Business Overview
Table 84. Medherant Transdermal Patch Drug Delivery System Product
Table 85. Medherant Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
Table 86. Medherant Recent Development
Table 87. Corium Company Detail
Table 88. Corium Business Overview
Table 89. Corium Transdermal Patch Drug Delivery System Product
Table 90. Corium Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
Table 91. Corium Recent Development
Table 92. Antares Pharma Company Detail
Table 93. Antares Pharma Business Overview
Table 94. Antares Pharma Transdermal Patch Drug Delivery SystemProduct
Table 95. Antares Pharma Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
Table 96. Antares Pharma Recent Development
Table 97. Syntropharma Company Detail
Table 98. Syntropharma Business Overview
Table 99. Syntropharma Transdermal Patch Drug Delivery SystemProduct
Table 100. Syntropharma Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
Table 101. Syntropharma Recent Development
Table 102. Teikoku Pharma Company Detail
Table 103. Teikoku Pharma Business Overview
Table 104. Teikoku Pharma Transdermal Patch Drug Delivery SystemProduct
Table 105. Teikoku Pharma Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
Table 106. Teikoku Pharma Recent Development
Table 107. Mylan Company Detail
Table 108. Mylan Business Overview
Table 109. Mylan Transdermal Patch Drug Delivery SystemProduct
Table 110. Mylan Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
Table 111. Mylan Recent Development
Table 112. Actavis Company Detail
Table 113. Actavis Business Overview
Table 114. Actavis Transdermal Patch Drug Delivery SystemProduct
Table 115. Actavis Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
Table 116. Actavis Recent Development
Table 117. Mundipharma Company Detail
Table 118. Mundipharma Business Overview
Table 119. Mundipharma Transdermal Patch Drug Delivery SystemProduct
Table 120. Mundipharma Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
Table 121. Mundipharma Recent Development
Table 122. Henan Lingrui Pharmaceutical Company Detail
Table 123. Henan Lingrui Pharmaceutical Business Overview
Table 124. Henan Lingrui Pharmaceutical Transdermal Patch Drug Delivery SystemProduct
Table 125. Henan Lingrui Pharmaceutical Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
Table 126. Henan Lingrui Pharmaceutical Recent Development
Table 127. Changzhou Siyao Company Detail
Table 128. Changzhou Siyao Business Overview
Table 129. Changzhou Siyao Transdermal Patch Drug Delivery SystemProduct
Table 130. Changzhou Siyao Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
Table 131. Changzhou Siyao Recent Development
Table 132. Rfl Pharmaceutical Company Detail
Table 133. Rfl Pharmaceutical Business Overview
Table 134. Rfl Pharmaceutical Transdermal Patch Drug Delivery SystemProduct
Table 135. Rfl Pharmaceutical Revenue in Transdermal Patch Drug Delivery System Business (2017-2022) & (US$ Million)
Table 136. Rfl Pharmaceutical Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Transdermal Patch Drug Delivery System Market Share by Type: 2021 VS 2028
Figure 2. Shunt Way Features
Figure 3. Intercellular Lipid Structure Pathway Features
Figure 4. Trans-cellular Pathway Features
Figure 5. Global Transdermal Patch Drug Delivery System Market Share by Application in 2021 & 2028
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Home Care Case Studies
Figure 9. Other Case Studies
Figure 10. Transdermal Patch Drug Delivery System Report Years Considered
Figure 11. Global Transdermal Patch Drug Delivery System Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Transdermal Patch Drug Delivery System Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Transdermal Patch Drug Delivery System Market Share by Region: 2021 VS 2028
Figure 14. Global Transdermal Patch Drug Delivery System Market Share by Players in 2021
Figure 15. Global Top Transdermal Patch Drug Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Patch Drug Delivery System as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Transdermal Patch Drug Delivery System Revenue in 2021
Figure 17. North America Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Transdermal Patch Drug Delivery System Market Share by Country (2017-2028)
Figure 19. United States Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Transdermal Patch Drug Delivery System Market Share by Country (2017-2028)
Figure 23. Germany Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Transdermal Patch Drug Delivery System Market Share by Region (2017-2028)
Figure 31. China Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Transdermal Patch Drug Delivery System Market Share by Country (2017-2028)
Figure 39. Mexico Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Transdermal Patch Drug Delivery System Market Share by Country (2017-2028)
Figure 43. Turkey Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Transdermal Patch Drug Delivery System Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Hisamitsu Pharmaceutical Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
Figure 46. Novartis Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
Figure 47. ProSolus Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
Figure 48. Tapemark Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
Figure 49. Tesa Labtec Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
Figure 50. NITTO DENKO CORPORATION Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
Figure 51. Noven Pharmaceuticals Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
Figure 52. LTS Lohmann Therapie-Systeme Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
Figure 53. Medherant Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
Figure 54. Corium Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
Figure 55. Antares Pharma Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
Figure 56. Syntropharma Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
Figure 57. Teikoku Pharma Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
Figure 58. Mylan Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
Figure 59. Actavis Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
Figure 60. Mundipharma Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
Figure 61. Henan Lingrui Pharmaceutical Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
Figure 62. Changzhou Siyao Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
Figure 63. Rfl Pharmaceutical Revenue Growth Rate in Transdermal Patch Drug Delivery System Business (2017-2022)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount